Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and adrenomedullin

pravastatin has been researched along with adrenomedullin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blankenberg, S; Colquhoun, D; Funke-Kaiser, A; Hunt, D; Mann, K; Simes, J; Sullivan, D; Sydow, K; Tonkin, AM; West, M; White, H; Zeller, T1
Anand, IS; Apple, FS; Cannon, CM; Christenson, RH; Clopton, P; Daniels, LB; deFilippi, C; Diercks, DB; Hogan, CJ; Hollander, JE; Jaffe, AS; Limkakeng, A; Maisel, AS; Marston, NA; McCord, J; Mueller, C; Nagurney, J; Neath, SX; Nowak, RM; Peacock, WF; Schreiber, D; Shah, KS; Vilke, GM; Wu, AH1
Blankenberg, S; Colquhoun, DM; Funke-Kaiser, A; Hague, W; Hunt, D; Keech, AC; Kirby, A; Nestel, P; Simes, J; Stewart, R; Sullivan, DR; Thompson, PL; Tonkin, AM; West, M; White, HD; Zeller, T1

Trials

3 trial(s) available for pravastatin and adrenomedullin

ArticleYear
Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
    International journal of cardiology, 2014, Mar-15, Volume: 172, Issue:2

    Topics: Adrenomedullin; Adult; Aged; Biomarkers; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Pravastatin; Predictive Value of Tests; Prognosis; Protein Precursors; Recurrence; Risk Assessment

2014
Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2015, Volume: 22, Issue:5

    Topics: Acute Disease; Adrenomedullin; Aged; Biomarkers; Chest Pain; Emergency Service, Hospital; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Risk Assessment; Risk Factors; Severity of Illness Index

2015
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
    International journal of cardiology, 2015, Dec-15, Volume: 201

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adrenomedullin; Adult; Aged; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Cystatin C; Female; Fibrin Fibrinogen Degradation Products; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pravastatin; Predictive Value of Tests; Prognosis; Risk Factors; Troponin I; Troponin T

2015